{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:33:47Z","timestamp":1793082827659,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006465","name":"Center for Advanced Materials Processing, Clarkson University","doi-asserted-by":"publisher","award":["P30-CA14051"],"award-info":[{"award-number":["P30-CA14051"]}],"id":[{"id":"10.13039\/100006465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020701","name":"Prime Minister's Office Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001474","name":"Singapore-MIT Alliance for Research and Technology Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016872","name":"MIT Koch Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"HHMI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RM1HG009490"],"award-info":[{"award-number":["RM1HG009490"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R35GM118062"],"award-info":[{"award-number":["R35GM118062"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.celrep.2026.117510","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T21:34:34Z","timestamp":1781040874000},"page":"117510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells"],"prefix":"10.1016","volume":"45","author":[{"given":"Brian H.","family":"Shim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q. Henry","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A.","family":"Queenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9943-7557","authenticated-orcid":false,"given":"David R.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117510_bib1","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa2210233","article-title":"Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma","volume":"387","author":"Rohaan","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117510_bib2","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198812223192527","article-title":"Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report","volume":"319","author":"Rosenberg","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117510_bib3","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.2014.58.9093","article-title":"Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells","volume":"33","author":"Stevanovi\u0107","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117510_bib4","doi-asserted-by":"crossref","first-page":"113345","DOI":"10.18632\/oncotarget.23007","article-title":"Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.celrep.2026.117510_bib5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00262-018-2174-4","article-title":"Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients","volume":"67","author":"Ben-Avi","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2026.117510_bib6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-18-1494","article-title":"Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers","volume":"9","author":"Parkhurst","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117510_bib7","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-18-0573","article-title":"T-cell Responses to TP53 \u201cHotspot\u201d Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers","volume":"24","author":"Deniger","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117510_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/2326-6066.CIR-17-0467","article-title":"T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma\u2014Implications for Adoptive Cell Therapy","volume":"6","author":"Andersen","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2026.117510_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","article-title":"Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma","volume":"596","author":"Oliveira","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117510_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117510_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","article-title":"Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers","volume":"25","author":"Scheper","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2026.117510_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-022-05126-w","article-title":"RASA2 ablation in T cells boosts antigen sensitivity and long-term function","volume":"609","author":"Carnevale","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117510_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj4008","article-title":"CRISPR activation and interference screens decode stimulation responses in primary human T cells","volume":"375","author":"Schmidt","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117510_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41586-023-06835-6","article-title":"Base-editing mutagenesis maps alleles to tune human T cell functions","volume":"625","author":"Schmidt","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117510_bib15","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.cell.2018.10.024","article-title":"Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function","volume":"175","author":"Shifrut","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117510_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41587-024-02235-x","article-title":"Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens","volume":"43","author":"Walsh","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2026.117510_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41586-025-09507-9","article-title":"Systematic discovery of CRISPR-boosted CAR T cell immunotherapies","volume":"646","author":"Datlinger","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117510_bib18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41586-025-09489-8","article-title":"In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma","volume":"646","author":"Knudsen","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117510_bib19","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo","volume":"42","author":"An","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2026.117510_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117510_bib21","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41587-024-02467-x","article-title":"Directed evolution of engineered virus-like particles with improved production and transduction efficiencies","volume":"43","author":"Raguram","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2026.117510_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg6986","article-title":"A human orthogonal IL-2 and IL-2R\u03b2 system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117510_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-024-07259-6","article-title":"Improving prime editing with an endogenous small RNA-binding protein","volume":"628","author":"Yan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117510_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s41467-018-03432-4","article-title":"Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein","volume":"9","author":"Nikolic","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117510_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41592-022-01436-z","article-title":"Antigen identification and high-throughput interaction mapping by reprogramming viral entry","volume":"19","author":"Dobson","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.117510_bib26","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1016\/j.cell.2022.11.016","article-title":"Engineered cell entry links receptor biology with single-cell genomics","volume":"185","author":"Yu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117510_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109207","article-title":"Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering","volume":"35","author":"Hamilton","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117510_bib28","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"In vivo human T cell engineering with enveloped delivery vehicles","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2026.117510_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adv2331","article-title":"Peptide-MHC\u2013targeted retroviruses enable in vivo expansion and gene delivery to tumor-specific T cells","volume":"11","author":"Xu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.117510_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR\u2013Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2026.117510_bib31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-018-0500-9","article-title":"In vivo CRISPR editing with no detectable genome-wide off-target mutations","volume":"561","author":"Akcakaya","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117510_bib32","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood-2018-04-843763","article-title":"A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens","volume":"132","author":"Hu","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2026.117510_bib33","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.4049\/jimmunol.180.9.6116","article-title":"Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions","volume":"180","author":"Robbins","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117510_bib34","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1038\/s41467-020-16755-y","article-title":"Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117510_bib35","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1158\/1078-0432.CCR-21-0849","article-title":"Identification and Validation of T-cell Receptors Targeting RAS Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy","volume":"27","author":"Levin","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117510_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67092","article-title":"The discriminatory power of the T cell receptor","volume":"10","author":"Pettmann","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2026.117510_bib37","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.4049\/jimmunol.179.9.5845","article-title":"High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines","volume":"179","author":"Zhao","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117510_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl5282","article-title":"Tuning T cell receptor sensitivity through catch bond engineering","volume":"376","author":"Zhao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117510_bib39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cell.2018.06.017","article-title":"Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding","volume":"174","author":"Sibener","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117510_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1170462","article-title":"Effects of HLA single chain trimer design on peptide presentation and stability","volume":"14","author":"Finton","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117510_bib41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature15399","article-title":"HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation","volume":"526","author":"Rosa","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117510_bib42","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/JVI.03330-14","article-title":"N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins","volume":"89","author":"Rosales Gerpe","year":"2015","journal-title":"J. Virol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726005887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726005887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:54:15Z","timestamp":1793080455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726005887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2211124726005887"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117510","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117510"}}